汉字News

← 汉字News
Chinese News for Learners
commerce
shāng yè
商业
·HSK 4

Abbott (pharmaceutical company)
Yǎpéi
雅培
for / at (a price)
$21 billion
èrbǎi yīshí yì měiyuán
二百一十亿美元
to complete / to finalize
wánchéng
完成
of
duì
Exact Sciences (cancer diagnostics company)
Exact Sciences
Exact Sciences
(possessive particle)
de
acquisition
shōugòu
收购

United States
Měiguó
美国
medical / healthcare
yīliáo
医疗
company / enterprise
qǐyè
企业
Abbott Laboratories
Yǎpéi
雅培
for / at
approximately
yuē
$21 billion
èrbǎi yīshí yì měiyuán
二百一十亿美元
to acquire
shōugòu
收购
(completion particle)
le
cancer
áizhèng
癌症
screening
shāichá
筛查
company
qǐyè
企业
Exact Sciences (cancer diagnostics firm)
Exact Sciences
Exact Sciences
this time / this deal
cǐ cì
此次
acquisition
shōugòu
收购
enables / allows
shǐ
使
Abbott
Yǎpéi
雅培
to gain / to obtain
huòdé
获得
(completion particle)
le
Cologuard (colorectal cancer screening test)
Cologuard
Cologuard
and other / etc.
děng
colorectal cancer
cháng ái
肠癌
detection / testing
jiǎncè
检测
product
chǎnpǐn
产品

March 23, 2026 at 12:00 PM

March 23rd
sān yuè èrshísān rì
三月二十三日
Abbott Laboratories
Yǎpéi
雅培
officially / formally
zhèngshì
正式
to complete / to finalize
wánchéng
完成
(completion particle)
le
of
duì
Exact Sciences (cancer diagnostics company)
Exact Sciences
Exact Sciences
(possessive particle)
de
acquisition
shōugòu
收购
transaction / deal
jiāoyì
交易
transaction amount
jīné
金额
is approximately
yuē wèi
约为
$21 billion
èrbǎi yīshí yì měiyuán
二百一十亿美元
this
cǐ cì
此次
acquisition
shōugòu
收购
(particle)
de
price
jiàgé
价格
is
wèi
per share
měi gǔ
每股
$105 per share
yībǎi líng wǔ měiyuán
一百零五美元
total
zǒng
enterprise
qǐyè
企业
value
jiàzhí
价值
approximately
yuē wèi
约为
$23 billion
èrbǎi sānshí yì měiyuán
二百三十亿美元
Exact Sciences
Exact Sciences
Exact Sciences
is
shì
a (company)
yī jiā
一家
focused on
zhuānzhù yú
专注于
cancer
áizhèng
癌症
early-stage
zǎoqī
早期
detection / testing
jiǎncè
检测
(particle)
de
company
gōngsī
公司
under its brands
qí xià
旗下
to own / to have
yōngyǒu
拥有
Cologuard (colorectal cancer test)
Cologuard
Cologuard
colorectal cancer
cháng ái
肠癌
screening
shāichá
筛查
product
chǎnpǐn
产品
Cologuard
Cologuard
Cologuard
through / by means of
tōngguò
通过
to analyze
fēnxī
分析
stool / fecal matter
fènbiàn
粪便
sample
yàngběn
样本
to (do something)
lái
to detect
jiǎncè
检测
colorectal cancer
jiézhícháng ái
结直肠癌
(particle)
de
early-stage
zǎoqī
早期
signs / indications
jìxiàng
迹象
without needing
wú xū
无需
to perform
jìnxíng
进行
traditional
chuántǒng
传统
(particle)
de
colonoscopy
cháng jìng
肠镜
examination
jiǎnchá
检查
Abbott
Yǎpéi
雅培
to state / to indicate
biǎoshì
表示
this
cǐ cì
此次
acquisition
shōugòu
收购
will
jiāng
allow / enable
shǐ
使
it / the company
in
zài
global
quánqiú
全球
valued at
jiàzhí
价值
$60 billion
liùbǎi yì měiyuán
六百亿美元
(particle)
de
cancer
áizhèng
癌症
diagnostics
zhěnduàn
诊断
market
shìchǎng
市场
in
zhōng
to gain
huòdé
获得
stronger / greater
gèng qiáng
更强
(particle)
de
competitiveness
jìngzhēnglì
竞争力
the two companies
liǎng jiā
两家
companies
gōngsī
公司
originally in
yuán yú
原于
2025
2025 nián
2025年
November
shíyī yuè
十一月
to announce
xuānbù
宣布
merger
hébìng
合并
intention
yìxiàng
意向
and in
bìng yú
并于
this year
jīnnián
今年
March
sān yuè
三月
to complete
wánchéng
完成
(completion particle)
le
final
zuìzhōng
最终
settlement / closing
jiāogē
交割
Abbott
Yǎpéi
雅培
to estimate / to expect
yùjì
预计
this
běn cì
本次
acquisition
shōugòu
收购
will
jiāng zài
将在
2026
2026 nián
2026年
remaining
yúxià
余下
within the remaining time
shíjiān nèi
时间内
for
wèi
the company
gōngsī
公司
to bring
dài lái
带来
approximately
yuē
$3 billion
sānshí yì měiyuán
三十亿美元
(particle)
de
incremental
zēngliàng
增量
sales revenue
xiāoshòu é
销售额
analysts
fēnxī rénshì
分析人士
to point out
zhǐchū
指出
this
cǐ cì
此次
acquisition
shōugòu
收购
is
shì
US
Měiguó
美国
healthcare
yīliáo
医疗
industry
hángyè
行业
in recent years
jìn nián lái
近年来
largest in scale
guīmó zuì dà
规模最大
(particle)
de
M&A deal / merger case
bìnggòu àn
并购案
one of
zhī yī
之一

New Words

Yǎpéi
雅培
Abbott
shōugòu
收购
acquisition
gōngsī
公司
company
áizhèng
癌症
cancer
jiǎncè
检测
detection
shāichá
筛查
screening
shìchǎng
市场
market
bìnggòu
并购
M&A

News in English

Business

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences

US healthcare company Abbott Laboratories acquired cancer screening firm Exact Sciences for approximately $21 billion, gaining the Cologuard colorectal cancer test.

On March 23, Abbott Laboratories formally completed acquisition of Exact Sciences cancer diagnostics company with transaction amount approximately $21 billion. The acquisition price is $105 per share, with total enterprise value approximately $23 billion. Exact Sciences is a company focused on early-stage cancer detection, with flagship Cologuard colorectal cancer screening product. Cologuard detects early-stage colorectal cancer signs by analyzing stool samples without needing traditional colonoscopy examination. Abbott stated this acquisition will enable it to gain stronger competitiveness in the $60 billion global cancer diagnostics market. The two companies originally announced merger intention in November 2025 and completed final closing this year in March. Abbott expects this acquisition will bring approximately $3 billion incremental sales revenue for the company within remaining 2026 time. Analysts pointed out this acquisition is one of largest US healthcare industry M&A deals in recent years.

More in Business

Momenta
Móméng tǎ
摩蒙塔
Hong Kong
Xiānggǎng
香港
listed
shàngshì
上市
fundraising
róngjī
融资
$752 million
7.52 yì měiyuán
7.52亿美元

Chinese Autonomous Driving Firm Momenta Debuts on Hong Kong Stock Exchange with 752 Million Fundraise

Samsung (South Korean electronics company)
Sānxīng
三星
SK Hynix (South Korean memory chipmaker)
SK Hǎilìshì
SK海力士
and / together with
Micron (US semiconductor company)
Měiguāng
美光
to race to / to vie in
jìngxiāng
竞相
to expand / to increase
kuòdà
扩大
AI / artificial intelligence
AI
AI
memory (computing)
nèicún
内存
chip / semiconductor chip
xīnpiàn
芯片
production capacity
chǎnnéng
产能

Samsung, SK Hynix and Micron Race to Expand AI Memory Chip Capacity

China
Zhōngguó
中国
artificial intelligence
réngōng zhìnéng
人工智能
company
gōngsī
公司
MiniMax (Chinese AI company)
MiniMax
MiniMax
to complete
wánchéng
完成
$2 billion
èrshí yì měiyuán
二十亿美元
fundraising / financing
róngzī
融资

Chinese AI Firm MiniMax Raises 2 Billion Dollars in Hong Kong Share Sale

PepsiCo
Bǎishì Gōngsī
百事公司
earnings / performance
yèjī
业绩
lower than / below
dīyú
低于
expectation / forecast
yùqī
预期
the United States
Měiguó
美国
stock market
gǔshì
股市
slightly / marginally
xiǎofú
小幅
to rise / to increase
shàngzhǎng
上涨

PepsiCo Earnings Disappoint as US Stocks Edge Higher